
Toniae M. Thomas
Examiner (ID: 11874)
| Most Active Art Unit | 2822 |
| Art Unit(s) | 1763, 2822, 1104, 2813 |
| Total Applications | 1101 |
| Issued Applications | 969 |
| Pending Applications | 9 |
| Abandoned Applications | 127 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20393525
[patent_doc_number] => 20250369000
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-12-04
[patent_title] => THERMOSTABLE POLYMERASE INHIBITOR COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 19/295912
[patent_app_country] => US
[patent_app_date] => 2025-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19295912
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/295912 | THERMOSTABLE POLYMERASE INHIBITOR COMPOSITIONS AND METHODS | Aug 10, 2025 | Pending |
Array
(
[id] => 19479885
[patent_doc_number] => 20240327927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => ACTIVE SURVEILLANCE AND RISK STRATIFICATION FOR PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 18/618857
[patent_app_country] => US
[patent_app_date] => 2024-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 242
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18618857
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/618857 | ACTIVE SURVEILLANCE AND RISK STRATIFICATION FOR PROSTATE CANCER | Mar 26, 2024 | Pending |
Array
(
[id] => 19684461
[patent_doc_number] => 20250003006
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-02
[patent_title] => USE OF TMED8 GENE IN PREPARATION OF DRUG AND DIAGNOSTIC KIT FOR PANCREATIC CANCER
[patent_app_type] => utility
[patent_app_number] => 18/603164
[patent_app_country] => US
[patent_app_date] => 2024-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6432
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18603164
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/603164 | USE OF TMED8 GENE IN PREPARATION OF DRUG AND DIAGNOSTIC KIT FOR PANCREATIC CANCER | Mar 11, 2024 | Pending |
Array
(
[id] => 19203200
[patent_doc_number] => 20240175099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-30
[patent_title] => DIRECT AMPLIFICATION AND DETECTION OF VIRAL AND BACTERIAL PATHOGENS
[patent_app_type] => utility
[patent_app_number] => 18/394431
[patent_app_country] => US
[patent_app_date] => 2023-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 236
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18394431
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/394431 | DIRECT AMPLIFICATION AND DETECTION OF VIRAL AND BACTERIAL PATHOGENS | Dec 21, 2023 | Pending |
Array
(
[id] => 19318639
[patent_doc_number] => 20240240182
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => HUMAN CHROMOSOME 9 OPEN READING FRAME 72 (C9ORF72) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/525924
[patent_app_country] => US
[patent_app_date] => 2023-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 100477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18525924
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/525924 | HUMAN CHROMOSOME 9 OPEN READING FRAME 72 (C9ORF72) iRNA AGENT COMPOSITIONS AND METHODS OF USE THEREOF | Nov 30, 2023 | Pending |
Array
(
[id] => 19142560
[patent_doc_number] => 20240141403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => Methods for Producing Recombinant Proteins
[patent_app_type] => utility
[patent_app_number] => 18/523908
[patent_app_country] => US
[patent_app_date] => 2023-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9339
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18523908
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/523908 | Methods for Producing Recombinant Proteins | Nov 29, 2023 | Pending |
Array
(
[id] => 19099045
[patent_doc_number] => 20240118273
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => METHODS, SYSTEMS, AND ARRAYS FOR BIOMOLECULAR ANALYSIS
[patent_app_type] => utility
[patent_app_number] => 18/368931
[patent_app_country] => US
[patent_app_date] => 2023-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 101
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18368931
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/368931 | METHODS, SYSTEMS, AND ARRAYS FOR BIOMOLECULAR ANALYSIS | Sep 14, 2023 | Pending |
Array
(
[id] => 19724325
[patent_doc_number] => 20250027076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => LIQUID-PHASE HYBRID CAPTURE METHOD AND LIQUID-PHASE HYBRID CAPTURE KIT
[patent_app_type] => utility
[patent_app_number] => 18/280967
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10482
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18280967
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/280967 | LIQUID-PHASE HYBRID CAPTURE METHOD AND LIQUID-PHASE HYBRID CAPTURE KIT | Aug 10, 2022 | Pending |
Array
(
[id] => 20295015
[patent_doc_number] => 20250320258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-10-16
[patent_title] => RNA RECOGNITION COMPLEX AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/565665
[patent_app_country] => US
[patent_app_date] => 2022-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10474
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18565665
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/565665 | RNA RECOGNITION COMPLEX AND USES THEREOF | May 31, 2022 | Pending |
Array
(
[id] => 16422189
[patent_doc_number] => 20200347387
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-05
[patent_title] => COMPOSITIONS AND METHODS FOR TARGET NUCLEIC ACID MODIFICATION
[patent_app_type] => utility
[patent_app_number] => 16/814591
[patent_app_country] => US
[patent_app_date] => 2020-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36070
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16814591
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/814591 | COMPOSITIONS AND METHODS FOR TARGET NUCLEIC ACID MODIFICATION | Mar 9, 2020 | Abandoned |
Array
(
[id] => 15711571
[patent_doc_number] => 20200102551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-02
[patent_title] => RECOMBINANT TYPE I CRISPR-CAS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 16/582269
[patent_app_country] => US
[patent_app_date] => 2019-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16582269
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/582269 | Recombinant type I CRISPR-Cas system | Sep 24, 2019 | Issued |
Array
(
[id] => 16932845
[patent_doc_number] => 20210198734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => DIRECT NUCLEIC ACID SEQUENCING METHOD
[patent_app_type] => utility
[patent_app_number] => 17/058167
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25701
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17058167
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/058167 | DIRECT NUCLEIC ACID SEQUENCING METHOD | May 23, 2019 | Pending |
Array
(
[id] => 15978481
[patent_doc_number] => 10669550
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-02
[patent_title] => Transgenic strain containing an isolated promoter
[patent_app_type] => utility
[patent_app_number] => 16/260032
[patent_app_country] => US
[patent_app_date] => 2019-01-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2355
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16260032
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/260032 | Transgenic strain containing an isolated promoter | Jan 27, 2019 | Issued |
Array
(
[id] => 14685705
[patent_doc_number] => 20190241967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => METHODS TO PREDICT CLINICAL OUTCOME OF CANCER
[patent_app_type] => utility
[patent_app_number] => 16/243207
[patent_app_country] => US
[patent_app_date] => 2019-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16243207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/243207 | METHODS TO PREDICT CLINICAL OUTCOME OF CANCER | Jan 8, 2019 | Abandoned |
Array
(
[id] => 14072961
[patent_doc_number] => 20190085368
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => MANUFACTURING METHODS FOR PRODUCTION OF RNA TRANSCRIPTS
[patent_app_type] => utility
[patent_app_number] => 16/144282
[patent_app_country] => US
[patent_app_date] => 2018-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16144282
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/144282 | MANUFACTURING METHODS FOR PRODUCTION OF RNA TRANSCRIPTS | Sep 26, 2018 | Abandoned |
Array
(
[id] => 13793311
[patent_doc_number] => 20190010194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => METHANOL-UTILIZING YEAST-DERIVED NOVEL PROTEIN AND METHOD FOR PRODUCING PROTEIN OF INTEREST USING SAME
[patent_app_type] => utility
[patent_app_number] => 16/142501
[patent_app_country] => US
[patent_app_date] => 2018-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16330
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16142501
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/142501 | METHANOL-UTILIZING YEAST-DERIVED NOVEL PROTEIN AND METHOD FOR PRODUCING PROTEIN OF INTEREST USING SAME | Sep 25, 2018 | Abandoned |
Array
(
[id] => 15204441
[patent_doc_number] => 20190364907
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => COMPOSITIONS OF MOSQUITOCIDAL CLOSTRIDIAL PROTEINS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/041703
[patent_app_country] => US
[patent_app_date] => 2018-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8516
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16041703
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/041703 | COMPOSITIONS OF MOSQUITOCIDAL CLOSTRIDIAL PROTEINS AND METHODS OF USE | Jul 19, 2018 | Abandoned |
Array
(
[id] => 14994287
[patent_doc_number] => 20190316101
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => METHODS AND COMPOSITIONS FOR GENETICALLY MANIPULATING GENES AND CELLS
[patent_app_type] => utility
[patent_app_number] => 16/039150
[patent_app_country] => US
[patent_app_date] => 2018-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9230
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16039150
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/039150 | METHODS AND COMPOSITIONS FOR GENETICALLY MANIPULATING GENES AND CELLS | Jul 17, 2018 | Abandoned |
Array
(
[id] => 13871413
[patent_doc_number] => 20190032047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => Methods and Compositions for Rapid Assembly of Genetic Modules
[patent_app_type] => utility
[patent_app_number] => 16/006002
[patent_app_country] => US
[patent_app_date] => 2018-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16006002
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/006002 | Methods and Compositions for Rapid Assembly of Genetic Modules | Jun 11, 2018 | Abandoned |
Array
(
[id] => 13778817
[patent_doc_number] => 20190002947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-03
[patent_title] => RECOMBINANT PRODUCTION METHOD
[patent_app_type] => utility
[patent_app_number] => 16/004992
[patent_app_country] => US
[patent_app_date] => 2018-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14779
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16004992
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/004992 | Recombinant production method | Jun 10, 2018 | Issued |